T Alarcón1, J I González-Montalvo2, R Hoyos2, J Diez-Sebastián3, A Otero4, J L Mauleon5. 1. Servicio de Geriatría, Hospital Universitario La Paz, IdiPaz, Paseo Castellana 261, 28046, Madrid, Spain. mteresa.alarcon@salud.madrid.org. 2. Servicio de Geriatría, Hospital Universitario La Paz, IdiPaz, Paseo Castellana 261, 28046, Madrid, Spain. 3. Servicio de Bioestadística, Hospital Universitario La Paz, IdiPaz, Madrid, Spain. 4. Departamento de Medicina Preventiva y Salud Pública, Universidad Autónoma de Madrid. IdiPaz, Madrid, Spain. 5. Servicio de Traumatología, Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
Abstract
BACKGROUND: Vitamin D and the parathyroid hormone (PTH) response play an important role in hip fracture patients. This study was carried out to determine the factors associated with the PTH response to different levels of vitamin D deficiency during hospitalization. METHODS: This was a cross-sectional study of patients over 64 years of age admitted with an acute fragility hip fracture between March 1st 2009 and November 30th 2012. Demographic, clinical, functional, and cognitive function were evaluated at admission and during hospitalization. Levels of 25-hydroxyvitamin D (25-OHD) and PTH were analyzed. Two 25-OHD cut-off points were considered, <12 ng/ml and 12-20 ng/ml. Multivariate logistic regression analysis was used. RESULTS: Mean age of the 607 patients included was 84.7 years (SD 7.10), and 81.9 % were women. The mean 25-OHD level in the total sample was 13.2 (SD 11.1) ng/ml. Levels of 25-OHD <12 ng/ml were present in 347 patients (57.2 %), of whom 158 (45.5 %) had secondary hyperparathyroidism (SHPT) (PTH >65 pg/ml). 25-OHD levels of 12-20 ng/ml were present in 168 (27.7 %) patients, of whom 47 (28 %) had SHPT. Following logistic regression, SHPT was associated in both groups (25-OHD <12 and 12-20 ng/ml) with a greater number of medical problems during hospitalization. In the 25-OHD group <12 ng/ml, SHPT was also associated with poorer glomerular filtration rates. CONCLUSION: The PTH response to vitamin D deficiency in hip fracture patients may be a marker for patients with higher risk of developing multiple medical problems, both when considering severe (<12 ng/ml) and moderate (12-20 ng/ml) vitamin D deficiency.
BACKGROUND:Vitamin D and the parathyroid hormone (PTH) response play an important role in hip fracturepatients. This study was carried out to determine the factors associated with the PTH response to different levels of vitamin D deficiency during hospitalization. METHODS: This was a cross-sectional study of patients over 64 years of age admitted with an acute fragility hip fracture between March 1st 2009 and November 30th 2012. Demographic, clinical, functional, and cognitive function were evaluated at admission and during hospitalization. Levels of 25-hydroxyvitamin D (25-OHD) and PTH were analyzed. Two 25-OHD cut-off points were considered, <12 ng/ml and 12-20 ng/ml. Multivariate logistic regression analysis was used. RESULTS: Mean age of the 607 patients included was 84.7 years (SD 7.10), and 81.9 % were women. The mean 25-OHD level in the total sample was 13.2 (SD 11.1) ng/ml. Levels of 25-OHD <12 ng/ml were present in 347 patients (57.2 %), of whom 158 (45.5 %) had secondary hyperparathyroidism (SHPT) (PTH >65 pg/ml). 25-OHD levels of 12-20 ng/ml were present in 168 (27.7 %) patients, of whom 47 (28 %) had SHPT. Following logistic regression, SHPT was associated in both groups (25-OHD <12 and 12-20 ng/ml) with a greater number of medical problems during hospitalization. In the 25-OHD group <12 ng/ml, SHPT was also associated with poorer glomerular filtration rates. CONCLUSION: The PTH response to vitamin Ddeficiency in hip fracturepatients may be a marker for patients with higher risk of developing multiple medical problems, both when considering severe (<12 ng/ml) and moderate (12-20 ng/ml) vitamin D deficiency.
Entities:
Keywords:
Elderly; Hip fracture; Outcomes; Secondary hyperparathyroidism; Vitamin D
Authors: M S Stein; J D Wark; S C Scherer; S L Walton; P Chick; M Di Carlantonio; J D Zajac; L Flicker Journal: J Am Geriatr Soc Date: 1999-10 Impact factor: 5.562
Authors: Denise G von Mühlen; Gail A Greendale; Cedric F Garland; Lori Wan; Elizabeth Barrett-Connor Journal: Osteoporos Int Date: 2005-06-01 Impact factor: 4.507
Authors: G Loncar; B Bozic; N Cvetinovic; H-D Dungen; M Lainscak; S von Haehling; W Doehner; Z Radojicic; B Putnikovic; T Trippel; V Popovic Journal: J Endocrinol Invest Date: 2016-10-13 Impact factor: 4.256
Authors: Carla Caffarelli; Nicola Mondanelli; Eduardo Crainz; Stefano Giannotti; Bruno Frediani; Stefano Gonnelli Journal: Int J Environ Res Public Health Date: 2022-06-15 Impact factor: 4.614